Submitted:
23 December 2025
Posted:
24 December 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Methods
2.1. Study Participants
2.2. Measurement of Sleep Disorders
2.3. Measurement of Organophosphate Esters in PM2.5
2.4. Covariates
2.5. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Supplementary Materials
Acknowledgments
References
- Hoffman, K.; Lorenzo, A.; Butt, C.M.; Adair, L.; Herring, A.H.; Stapleton, H.M.; Daniels, J.L. Predictors of urinary flame retardants in pregnancy. Environ. Int. 2017, 98, 96–101. [Google Scholar] [CrossRef]
- Poma, G.; Glynn, A.; Malarvannan, G.; Covaci, A.; Darnerud, P.O. Dietary intake of phosphorus flame retardants. Food Chem. Toxicol. 2017, 100, 1–7. [Google Scholar] [CrossRef]
- Romano, M.E.; Hawley, N.L.; Eliot, M.; Calafat, A.M.; Jayatilaka, N.K.; Kelsey, K.; McGarvey, S.; Phipps, M.G.; Savitz, D.A.; Werner, E.F.; Braun, J.M. Variability and predictors of urinary concentrations of organophosphate flame retardant metabolites among pregnant women in Rhode Island. Environ. Health 2017, 16, 40. [Google Scholar] [CrossRef] [PubMed]
- Hoffman, K.; Butt, C.M.; Chen, A.; Limkakeng, A.T.; Stapleton, H.M. High exposure to organophosphate flame retardants in infants: Associations with baby products. Environ. Sci. Technol. 2015, 49, 14554–14559. [Google Scholar] [CrossRef]
- Jia, T.; Gao, L.; Liu, W.; Guo, B.; He, Y.; Xu, X.; Mao, T.; Deng, J.; Li, D.; Tao, F.; Wang, W. Screening of organophosphate esters in different indoor environments: Distribution, diffusion, and risk assessment. Environ. Pollut. 2023, 327, 121576. [Google Scholar] [CrossRef] [PubMed]
- Gu, L.; Hu, B.; Fu, Y.; Zhou, W.; Li, X.; Huang, K.; Zhang, Q.; Fu, J.; Zhang, H.; Zhang, A.; Fu, J.; Jiang, G. Occurrence and risk assessment of organophosphate esters in global aquatic products. Water Res. 2023, 240, 120083. [Google Scholar] [CrossRef] [PubMed]
- Van der Veen, I.; de Boer, J. Phosphorus flame retardants: Properties, production, environmental occurrence, toxicity and analysis. Chemosphere 2012, 88, 1119–1153. [Google Scholar] [CrossRef]
- Ospina, M.; Jayatilaka, N.K.; Wong, L.Y.; Restrepo, P.; Calafat, A.M. Exposure to organophosphate flame retardant chemicals in the U.S. general population. Environ. Int. 2018, 110, 32–41. [Google Scholar] [CrossRef]
- Doherty, B.T.; Hammel, S.C.; Daniels, J.L.; Stapleton, H.M.; Hoffman, K. Organophosphate esters: Are these flame retardants and plasticizers affecting children’s health? Curr. Environ. Health Rep. 2019, 6, 201–213. [Google Scholar] [CrossRef]
- Van den Eede, N.; Heffernan, A.L.; Aylward, L.L.; Hobson, P.; Neels, H.; Mueller, J.F.; Covaci, A. Age as a determinant of phosphate flame retardant exposure of the Australian population. Environ. Int. 2015, 74, 1–8. [Google Scholar] [CrossRef]
- Sugeng, E.J.; Leonards, P.E.G.; van de Bor, M. Brominated and organophosphorus flame retardants in body wipes and house dust of Dutch toddlers. Environ. Res. 2017, 158, 789–797. [Google Scholar] [CrossRef]
- Langer, S.; de Wit, C.A.; Giovanoulis, G.; Fäldt, J.; Karlson, L. The effect of reduction measures on concentrations of hazardous semivolatile organic compounds in indoor air and dust of Swedish preschools. Indoor Air 2021, 31, 1673–1682. [Google Scholar] [CrossRef]
- Cequier, E.; Sakhi, A.K.; Marcé, R.M.; Becher, G.; Thomsen, C. Human exposure pathways to organophosphate triesters—A biomonitoring study of mother–child pairs. Environ. Int. 2015, 75, 159–165. [Google Scholar] [CrossRef]
- Araki, A.; Bastiaensen, M.; Ait Bamai, Y.; Van den Eede, N.; Kawai, T.; Tsuboi, T.; Ketema, R.M.; Covaci, A.; Kishi, R. Associations between allergic symptoms and phosphate flame retardants in dust and their urinary metabolites among school children. Environ. Int. 2018, 119, 438–446. [Google Scholar] [CrossRef]
- Araki, A.; Ait Bamai, Y.; Bastiaensen, M.; Van den Eede, N.; Kawai, T.; Tsuboi, T.; Miyashita, C.; Itoh, S.; Goudarzi, H.; Konno, S.; Covaci, A.; Kishi, R. Combined exposure to phthalate esters and phosphate flame retardants and plasticizers and their associations with wheeze and allergy symptoms among school children. Environ. Res. 2020, 183, 109212. [Google Scholar] [CrossRef]
- Canbaz, D.; Logiantara, A.; van Ree, R.; van Rijt, L.S. Immunotoxicity of organophosphate flame retardants TPHP and TDCIPP on murine dendritic cells in vitro. Chemosphere 2017, 177, 56–64. [Google Scholar] [CrossRef]
- Yanagisawa, R.; Koike, E.; Win-Shwe, T.T.; Kawaguchi, M.; Takano, H. Impact of dietary exposure to low-dose tris(1,3-dichloro-2-propyl) phosphate in allergic asthmatic mice. Immunotoxicol. 2021, 43, 599–610. [Google Scholar] [CrossRef]
- Araki, A.; Saito, I.; Kanazawa, A.; Morimoto, K.; Nakayama, K.; Shibata, E.; Tanaka, M.; Takigawa, T.; Yoshimura, T.; Chikara, H.; Saijo, Y.; Kishi, R. Phosphorus flame retardants in indoor dust and their relation to asthma and allergies of inhabitants. Indoor Air 2014, 24, 3–15. [Google Scholar] [CrossRef] [PubMed]
- Hardos, J.E.; Whitehead, L.W.; Han, I.; Ott, D.K.; Waller, D.K. Depression prevalence and exposure to organophosphate esters in aircraft maintenance workers. Aerosp. Med. Hum. Perform. 2016, 87, 712–717. [Google Scholar] [CrossRef] [PubMed]
- Yin, J.; Jin, X.; Shan, Z.; Li, S.; Huang, H.; Li, P.; Peng, X.; Peng, Z.; Yu, K.; Bao, W.; Yang, W.; Chen, X.; Liu, L. Relationship of sleep duration with all-cause mortality and cardiovascular events. J. Am. Heart Assoc. 2017, 6, e005947. [Google Scholar] [CrossRef] [PubMed]
- Lao, X.Q.; Liu, X.; Deng, H.B.; Chan, T.C.; Ho, K.F.; Wang, F.; Vermeulen, R.; Tam, T.; Wong, M.C.S.; Tse, L.A.; Chang, L.Y.; Yeoh, E.K. Sleep quality, sleep duration, and the risk of coronary heart disease: A prospective cohort study. J. Clin. Sleep Med. 2018, 14, 109–117. [Google Scholar] [CrossRef]
- Reeve, S.; Sheaves, B.; Freeman, D. Sleep disorders in early psychosis: Incidence, severity, and association with clinical symptoms. Schizophr. Bull. 2019, 45, 287–295. [Google Scholar] [CrossRef]
- Kang, X.; Li, J.; Luo, J.; Zhang, D. Associations between organophosphate ester metabolites and sleep disorder and trouble sleeping in adults: A machine-learning approach. Environ. Sci. Pollut. Res. 2022, 29, 67287–67300. [Google Scholar] [CrossRef]
- Bekele, T.G.; Zhao, H.; Yang, J.; Chegen, R.G.; Chen, J.; Mekonen, S.; Qadeer, A. Environmental occurrence, analysis, bioaccumulation, and toxicity of organophosphate esters: A review. Environ. Sci. Pollut. Res. 2021, 28, 49507–49528. [Google Scholar] [CrossRef] [PubMed]
- Fuhrimann, S.; van den Brenk, I.; Atuhaire, A.; Mubeezi, R.; Staudacher, P.; Huss, A.; Kromhout, H. Recent pesticide exposure affects sleep: A cross-sectional study among smallholder farmers in Uganda. Environ. Int. 2022, 158, 106878. [Google Scholar] [CrossRef]
- Darwiche, W.; Gay-Quéheillard, J.; Delanaud, S.; El Khayat El Sabbouri, H.; Khachfe, H.; Joumaa, W.; Bach, V.; Ramadan, W. Impact of chronic exposure to chlorpyrifos on respiratory parameters and sleep apnea in juvenile and adult rats. PLoS ONE 2018, 13, e0191237. [Google Scholar] [CrossRef]
- Morgan, D.; Tsai, S.C. Sleep and the endocrine system. Crit. Care Clin. 2015, 31, 403–418. [Google Scholar] [CrossRef] [PubMed]
- Smith, P.C.; Mong, J.A. Neuroendocrine control of sleep. Curr. Top. Behav. Neurosci. 2019, 43, 353–378. [Google Scholar] [PubMed]
- Wu, L.Y.; He, W.T.; Zeeshan, M.; Zhou, Y.; Zhang, Y.T.; Liang, L.X.; Huang, J.W.; Zhou, J.X.; Zhao, K.; Bao, W.W.; Lin, L.Z.; Gui, Z.H.; Liu, R.Q.; Hu, L.W.; Wang, Z.; Dong, G.H. Incidence of respiratory diseases associated with per- and polyfluoroalkyl substances in PM2.5. J. Hazard. Mater. 2025, 494, 138485. [Google Scholar] [CrossRef]
- Taylor, R.W.; Haszard, J.J.; Jackson, R.; Morrison, S.; Beebe, D.W.; Meredith-Jones, K.A.; Elder, D.E.; Galland, B.C. Effect of sleep changes on health-related quality of life in healthy children. JAMA Netw. Open 2023, 6, e233005. [Google Scholar] [CrossRef]
- Cooper, R.; Di Biase, M.A.; Bei, B.; Quach, J.; Cropley, V. Associations of changes in sleep and emotional and behavioral problems from late childhood to early adolescence. JAMA Psychiatry 2023, 80, 585–596. [Google Scholar] [CrossRef] [PubMed]
- Huang, M.M.; Qian, Z.; Wang, J.; Vaughn, M.G.; Lee, Y.L.; Dong, G.H. Validation of the sleep disturbance scale for children and prevalence of parent-reported sleep disorder symptoms in Chinese children. Sleep Med. 2014, 15, 923–928. [Google Scholar] [CrossRef]
- Bruni, O.; Ottaviano, S.; Guidetti, V.; Romoli, M.; Innocenzi, M.; Cortesi, F.; Giannotti, F. The Sleep Disturbance Scale for Children (SDSC): Construction and validation of an instrument to evaluate sleep disturbances in childhood and adolescence. J. Sleep Res. 1996, 5, 251–261. [Google Scholar] [CrossRef]
- Hirshkowitz, M.; Whiton, K.; Albert, S.M.; Alessi, C.; Bruni, O.; DonCarlos, L.; Hazen, N.; Herman, J.; Katz, E.S.; Kheirandish-Gozal, L.; Neubauer, D.N.; O’Donnell, A.E.; Ohayon, M.; Peever, J.; Rawding, R.; Sachdeva, R.C.; Setters, B.; Vitiello, M.V.; Ware, J.C.; Adams Hillard, P.J. National Sleep Foundation’s sleep time duration recommendations: Methodology and results summary. Sleep Health 2015, 1, 40–43. [Google Scholar] [CrossRef]
- Ohayon, M.; Wickwire, E.M.; Hirshkowitz, M.; Albert, S.M.; Avidan, A.; Daly, F.J.; Dauvilliers, Y.; Ferri, R.; Fung, C.; Gozal, D.; Hazen, N.; Krystal, A.; Lichstein, K.; Mallampalli, M.; Plazzi, G.; Rawding, R.; Scheer, F.A.; Somers, V.; Vitiello, M.V. National Sleep Foundation’s sleep quality recommendations: First report. Sleep Health 2017, 3, 6–19. [Google Scholar] [CrossRef]
- Gui, Z.H.; Heinrich, J.; Morawska, L.; Zhao, T.Y.; Yim, S.H.; Lao, X.Q.; Gao, M.; Chen, D.H.; Ma, H.M.; Lin, L.Z.; Liu, R.Q.; Dong, G.H. Long-term exposure to ozone and sleep disorders in children: A multicity study in China. Environ. Res. 2024, 260, 119553. [Google Scholar] [CrossRef]
- Liu, L.S.; Guo, Y.T.; Wu, Q.Z.; Zeeshan, M.; Qin, S.J.; Zeng, H.X.; Lin, L.Z.; Chou, W.C.; Yu, Y.J.; Dong, G.H.; Zeng, X.W. Per- and polyfluoroalkyl substances in ambient fine particulate matter in the Pearl River Delta, China. Environ. Pollut. 2023, 334, 122138. [Google Scholar] [CrossRef] [PubMed]
- Liu, X.; Chen, D.; Yu, Y.; Zeng, X.; Li, L.; Xie, Q.; Yang, M.; Wu, Q.; Dong, G. Novel organophosphate esters in airborne particulate matter. Environ. Sci. Technol. 2020, 54, 13771–13777. [Google Scholar] [CrossRef]
- Zeng, Y.; Chen, S.J.; Liang, Y.H.; Zhu, C.Y.; Liu, Z.; Guan, Y.F.; Ma, H.M.; Mai, B.X. Traditional and novel organophosphate esters in PM2.5 of a megacity, southern China. Environ. Pollut. 2021, 284, 117208. [Google Scholar] [CrossRef]
- Liu, X.; Cai, Y.; Wang, Y.; Xu, S.; Ji, K.; Choi, K. Effects of TDCPP and TPP on sex-dependent alterations of thyroid hormones in adult zebrafish. Ecotoxicol. Environ. Saf. 2019, 170, 25–32. [Google Scholar] [CrossRef] [PubMed]
- Percy, Z.; Vuong, A.M.; Xu, Y.; Xie, C.; Ospina, M.; Calafat, A.M.; Hoofnagle, A.; Lanphear, B.P.; Braun, J.M.; Cecil, K.M.; Dietrich, K.N.; Yolton, K.; Chen, A. Maternal urinary organophosphate esters and alterations in maternal and neonatal thyroid hormones. Am. J. Epidemiol. 2021, 190, 1793–1802. [Google Scholar] [CrossRef]
- Ren, X.; Cao, L.; Yang, Y.; Wan, B.; Wang, S.; Guo, L. In vitro assessment of thyroid hormone receptor activity of four organophosphate esters. J. Environ. Sci. 2016, 45, 185–190. [Google Scholar] [CrossRef]
- Yao, Y.; Li, M.; Pan, L.; Duan, Y.; Duan, X.; Li, Y.; Sun, H. Exposure to organophosphate ester flame retardants and plasticizers during pregnancy. Environ. Int. 2021, 146, 106215. [Google Scholar] [CrossRef]
- Zhang, M.; Zhang, W.; Tan, J.; Zhao, M.; Zhang, Q.; Lei, P. Role of hypothyroidism in obstructive sleep apnea: A meta-analysis. Curr. Med. Res. Opin. 2016, 32, 1059–1064. [Google Scholar] [CrossRef] [PubMed]
- Takeuchi, S.; Kitamura, T.; Ohbuchi, T.; Koizumi, H.; Takahashi, R.; Hohchi, N.; Suzuki, H. Relationship between sleep apnea and thyroid function. Sleep Breath. 2015, 19, 85–89. [Google Scholar] [CrossRef] [PubMed]
- Thavaraputta, S.; Dennis, J.A.; Laoveeravat, P.; Nugent, K.; Rivas, A.M. Hypothyroidism and its association with sleep apnea among adults in the United States. J. Clin. Endocrinol. Metab. 2019, 104, 4990–4997. [Google Scholar] [CrossRef] [PubMed]
- Shinno, H.; Inami, Y.; Inagaki, T.; Kawamukai, T.; Utani, E.; Nakamura, Y.; Horiguchi, J. Successful treatment with levothyroxine for idiopathic hypersomnia patients with subclinical hypothyroidism. Gen. Hosp. Psychiatry 2009, 31, 190–193. [Google Scholar] [CrossRef]
- Colović, M.B.; Krstić, D.Z.; Lazarević-Pašti, T.D.; Bondžić, A.M.; Vasić, V.M. Acetylcholinesterase inhibitors: Pharmacology and toxicology. Curr. Neuropharmacol. 2013, 11, 315–335. [Google Scholar] [CrossRef]
- Dishaw, L.V.; Powers, C.M.; Ryde, I.T.; Roberts, S.C.; Seidler, F.J.; Slotkin, T.A.; Stapleton, H.M. Is the PentaBDE replacement, tris(1,3-dichloro-2-propyl) phosphate (TDCPP), a developmental neurotoxicant? Studies in PC12 cells. Toxicol. Appl. Pharmacol. 2011, 256, 281–289. [Google Scholar] [CrossRef]
- Boyle, M.; Buckley, J.P.; Quirós-Alcalá, L. Associations between urinary organophosphate ester metabolites and measures of adiposity among U.S. children and adults: NHANES 2013–2014. Environ. Int. 2019, 127, 754–763. [Google Scholar] [CrossRef]
- Luo, K.; Aimuzi, R.; Wang, Y.; Nian, M.; Zhang, J. Urinary organophosphate ester metabolites, glucose homeostasis and prediabetes in adolescents. Environ. Pollut. 2020, 267, 115607. [Google Scholar] [CrossRef]
- Ma, Y.; Peng, L.; Kou, C.; Hua, S.; Yuan, H. Associations of overweight, obesity and related factors with sleep-related breathing disorders and snoring in adolescents. Int. J. Environ. Res. Public Health 2017, 14, 194. [Google Scholar] [CrossRef] [PubMed]
- Muscogiuri, G.; Barrea, L.; Annunziata, G.; Di Somma, C.; Laudisio, D.; Colao, A.; Savastano, S. Obesity and sleep disturbance: The chicken or the egg? Crit. Rev. Food Sci. Nutr. 2019, 59, 2158–2165. [Google Scholar] [CrossRef] [PubMed]
- Parisi, P.; Bruni, O.; Villa, M.P.; Verrotti, A.; Miano, S.; Luchetti, A.; Curatolo, P. The relationship between sleep and epilepsy: The effect on cognitive functioning in children. Dev. Med. Child Neurol. 2010, 52, 805–810. [Google Scholar] [CrossRef] [PubMed]
- Rey, A.E.; Guignard-Perret, A.; Imler-Weber, F.; Garcia-Larrea, L.; Mazza, S. Improving sleep, cognitive functioning and academic performance with sleep education at school in children. Learn. Instr. 2020, 65, 101270. [Google Scholar] [CrossRef]
- Short, M.A.; Bartel, K.; Carskadon, M.A. Sleep and mental health in children and adolescents. In Sleep and Health; Academic Press: London, UK, 2019; pp. 435–445. [Google Scholar]

| Variables | Total sleep disorder (yes) (n=36,824) |
Total sleep disorder (No) (n=73,345) | Total population (n=110,169) |
P-value |
|---|---|---|---|---|
| Age, mean (SD), years | 12.0 (2.9) | 11.3 (2.8) | 11.6 (2.8) | < 0.01 |
| Sex | 0.370 | |||
| Boys, N(%) | 19,543(53.1) | 39,136 (53.4) | 58,679 (53.3) | |
| Girls, N(%) | 17,281 (46.9) | 34,209 (46.6) | 51,490 (46.7) | |
| Preterm birth, N(%) | 2,415 (6.6) | 3,677 (5.0) | 6,092 (5.5) | < 0.01 |
| Breastfeeding, N(%) | 21,450 (58.3) | 42,500 (57.9) | 63,950 (58.0) | 0.337 |
| Physical activity, N(%) | 10,791 (29.9) | 23,347 (31.8) | 34,138 (31.0) | < 0.01 |
| Parental education ≥ high school, N(%) | 17,437 (47.4) | 33,504 (45.7) | 50,941 (46.2) | < 0.01 |
| Annual household income, N (%), Yuan | 0.073 | |||
| 2,937 (8.0) | 6,159 (8.4) | 9,096 (8.3) | ||
| 10,001-30,000 | 4,107 (11.2) | 8,281 (11.3) | 12,388 (11.2) | |
| 30,001-100,000 | 5,859 (15.9) | 11,807 (16.1) | 17,666 (16.0) | |
| 100,001-200,000 | 12,121 (32.9) | 23,775 (32.4) | 35,896 (32.6) | |
| >200,000 | 11,800(32.0) | 23,323(31.8) | 35,123(31.9) | |
| Secondhand smoke exposure, N(%) | 13,795 (37.5) | 24,360 (33.2) | 38,155 (34.6) | < 0.01 |
| Home renovation exposure in past 2 years, N (%) | 17,170 (46.6) | 37,183 (50.7) | 54,355 (49.3) | < 0.01 |
| Pets at home, N (%) | 7,423 (20.2) | 13,091 (17.8) | 20,514 (18.6) | < 0.01 |
| Factory location, N(%) | < 0.01 | |||
| No factory | 27,302(74.1) | 56,928 (77.6) | 84,230 (76.5) | |
| Nearby | 6,634 (18.0) | 11,785(16.1) | 18,419(16.7) | |
| Far away | 2,888 (7.8) | 4,632 (6.3) | 7,520 (6.8) | |
| Low Birth Weight, N(%) | 2619(7.1) | 3026(4.1) | 5,645(5.1) | < 0.01 |
| Caesarian, N(%) | 13,998(38.0) | 27,659(37.7) | 41,657(37.8) | 0.332 |
| Per Capita Living Area, N(%) | < 0.01 | |||
| Small | 13,645 (37.1) | 26,996 (36.8) | 40,641 (36.9) | |
| Medium | 14,758 (40.1) | 31,658 (43.2) | 46,416 (42.1) | |
| High | 8,421 (22.9) | 14,691 (20.0) | 23,112 (21.0) | |
| Mold Exposure,N(%) | 16,903 (45.9) | 29,324 (40.0) | 46,227 (42.0) | < 0.01 |
| City,N(%) | < 0.01 | |||
| Foshan | 6,006(16.3) | 13,500(18.4) | 19,506(17.7) | |
| Guangzhou | 13,997(38.0) | 22,309(30.4) | 36,306(33.0) | |
| Shenzhen | 7,495(20.4) | 12,223(16.7) | 19,718(17.9) | |
| Zhonshang | 6,665(18.1) | 17,972(24.5) | 24,637(22.4) | |
| Zhuhai | 2,661(7.2) | 7,341(10.0) | 10,002(9.1) |
| OPEs | Min (pg/m3 ) |
Q1 (pg/m3 ) |
Median (pg/m3 ) |
Q3 (pg/m3 ) |
Max (pg/m3 ) |
MDLs (pg/m3) |
|---|---|---|---|---|---|---|
| TEP | 12.302 | 59.949 | 104.498 | 195.435 | 4531.727 | 41.529 |
| TCEP | 0.122 | 209.281 | 362.057 | 569.729 | 5140.226 | 10.991 |
| TCIPP | 18.868 | 80.818 | 111.915 | 172.158 | 747.656 | 10.914 |
| TDCIPP | 7.944 | 35.914 | 57.237 | 96.068 | 384.575 | 1.490 |
| TPHP | 0.003 | 122.303 | 323.737 | 573.984 | 2473.357 | 3.653 |
| EHDPH | 1.393 | 20.713 | 34.662 | 66.828 | 1379.108 | 5.148 |
| TBOEP | 6.738 | 202.701 | 303.260 | 447.972 | 5592.327 | 1.218 |
| T2IPPP | 0.474 | 5.954 | 10.378 | 20.876 | 237.297 | 0.219 |
| TEHP | 9.510 | 230.330 | 364.495 | 548.267 | 2415.413 | 1.817 |
| T34DMPP | 0.007 | 0.010 | 0.015 | 10.714 | 47.464 | 0.039 |
| β | Total sleep problem | GSD | DIMS | SBD | DA | SHY | DOES | SWTD | Shorter sleep duration | Longer sleep latency |
|---|---|---|---|---|---|---|---|---|---|---|
| TEP | 0.086 | 0.048 | 0.051 | 0.040 | 0.044 | 0.049 | 0.057 | 0.047 | 0.097 | 0.060 |
| TCEP | 0.127 | 0.102 | 0.107 | 0.076 | 0.114 | 0.087 | 0.103 | 0.101 | 0.113 | 0.110 |
| TCIPP | 0.272 | 0.245 | 0.215 | 0.230 | 0.214 | 0.186 | 0.262 | 0.219 | 0.230 | 0.193 |
| TDCIPP | 0.410 | 0.275 | 0.277 | 0.238 | 0.233 | 0.243 | 0.295 | 0.217 | 0.465 | 0.382 |
| TPHP) | 0.324 | 0.321 | 0.292 | 0.302 | 0.248 | 0.257 | 0.318 | 0.294 | 0.307 | 0.268 |
| EHDPH | 0.022 | 0.029 | 0.022 | 0.023 | 0.002 | 0.024 | 0.036 | 0.024 | 0.025 | 0.012 |
| TBOEP | 0.035 | 0.050 | 0.046 | 0.063 | 0.040 | 0.061 | 0.035 | 0.070 | -0.002 | 0.028 |
| T2IPPP | 0.116 | 0.097 | 0.092 | 0.083 | 0.079 | 0.070 | 0.122 | 0.067 | 0.147 | 0.109 |
| TEHP | 0.421 | 0.281 | 0.282 | 0.279 | 0.258 | 0.203 | 0.307 | 0.217 | 0.481 | 0.389 |
| T34DMPP | 0.213 | 0.181 | 0.158 | 0.203 | 0.145 | 0.198 | 0.209 | 0.219 | 0.202 | 0.134 |
| Sleep Disorders | Organophosphate esters (OPE) in PM2.5 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| TEP | TCEP | TCIPP | TDCIPP | TPHP | EHDPH | TBOEP | T2IPPP | TEHP | T34DMPP | |
| OR(95% CI) | OR(95% CI) | OR(95% CI) | OR(95% CI) | OR(95% CI) | OR(95% CI) | OR(95% CI) | OR(95% CI) | OR(95% CI) | OR(95% CI) | |
| Total SD | 1.09(1.08-1.09) | 1.13(1.12-1.14) | 1.31(1.29-1.33) | 1.50(1.48-1.52) | 1.38(1.35-1.40) | 1.02(1.01-1.03) | 1.03(1.02-1.04) | 1.12(1.11-1.13) | 1.52(1.50-1.54) | 1.23(1.21-1.26) |
| GSD | 1.05(1.03-1.06) | 1.11(1.09-1.12) | 1.12(1.10-1.14) | 1.31(1.28-1.35) | 1.37(1.32-1.42) | 1.02(1.02-1.0) | 1.05(1.03-1.06) | 1.10(1.08-1.11) | 1.32(1.28-1.35) | 1.19(1.15-1.24) |
| DIMS | 1.05(1.04-1.06) | 1.11(1.09-1.12) | 1.23(1.21-1.26) | 1.31(1.28-1.34) | 1.33(1.29-1.37) | 1.02(1.01-1.03) | 1.04(1.03-1.05) | 1.09(1.08-1.10) | 1.32(1.29-1.35) | 1.16(1.13-1.20) |
| SBD | 1.04(1.02-1.05) | 1.08(1.06-1.09) | 1.25(1.22-1.28) | 1.26(1.23-1.30) | 1.34(1.30-1.39) | 1.02(1.01-1.03) | 1.06(1.05-1.07) | 1.08(1.06-1.10) | 1.31(1.28-1.35) | 1.22(1.17-1.26) |
| DA | 1.04(1.03-1.05) | 1.12(1.10-1.13) | 1.23(1.20-1.27) | 1.26(1.22-1.30) | 1.28(1.22-1.33) | 1.00(0.99-1.01) | 1.04(1.02-1.05) | 1.08(1.06-1.09) | 1.29(1.25-1.33) | 1.15(1.11-1.20) |
| SWTD | 1.04(1.03-1.06) | 1.10(1.09-1.12) | 1.24(1.21-1.27) | 1.24(1.20-1.27) | 1.33(1.28-1.39) | 1.02(1.01-1.03) | 1.07(1.05-1.08) | 1.06(1.05-1.08) | 1.23(1.20-1.27) | 1.24(1.19-1.29) |
| DOES | 1.05(1.04-1.07) | 1.10(1.09-1.12) | 1.29(1.36-1.32) | 1.34(1.31-1.37) | 1.37(1.32-1.42) | 1.03(1.02-1.04) | 1.03(1.02-1.04) | 1.12(1.11-1.14) | 1.35(1.32-1.39) | 1.23(1.18-1.27) |
| SHY | 1.05(1.04-1.06) | 1.09(1.07-1.10) | 1.20(1.17-1.22) | 1.27(1.24-1.30) | 1.28(1.24-1.33) | 1.02(1.01-1.03) | 1.06(1.05-1.07) | 1.07(1.05-1.08) | 1.22(1.19-1.25) | 1.21(1.17-1.25) |
| SSD | 1.10(1.09-1.11) | 1.12(1.10-1.13) | 1.25(1.23-1.27) | 1.59(1.56-1.61) | 1.35(1.32-1.38) | 1.02(1.01-1.03) | 0.99(0.98-1.00) | 1.15(1.14-1.16) | 1.61(1.59-1.64) | 1.22(1.19-1.25) |
| LSS | 1.06(1.04-1.07) | 1.11(1.09-1.13) | 1.21(1.17-1.24) | 1.46(1.42-1.50) | 1.30(1.25-1.35) | 1.01(1.00-1.02) | 1.02(1.01-1.04) | 1.11(1.09-1.13) | 1.47(1.43-1.51) | 1.14(1.10-1.19) |
| Sleep disorder outcome | OR (95% CI) | Top three contributing OPEs |
|---|---|---|
| Total SD | 2.74(2.68-2.80) | TEHP, TEP, TCIPP |
| GSD | 2.50(2.38-2.63) | TCIPP, TEP,EHDPH |
| DIMS | 2.28(2.18-2.37) | TCIPP, TEP,EHDPH |
| SBD | 2.21(2.11-2.32) | T34DMPP, TCEP, EHDPH |
| DA | 2.02(1.91-2.12) | TEHP,TCIPP, TCEP |
| SWTD | 2.17(2.06-2.29) | T34DMPP, TCIPP, TEP |
| DOES | 2.54(2.42-2.64) | TCIPP,TCEP,TEP |
| SHY | 2.07(1.98-2.16) | T34DMPP,TCEP,TEP |
| SSD | 2.85(2.77-2.92) | TEHP,TEP,TDCIPP |
| LSS | 2.46(2.34-2.59) | TEHP,TEP,TCIPP |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
